Preferences for Alternative Care Modalities Among French Adults With Chronic Illness.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 12 2021
Historique:
entrez: 29 12 2021
pubmed: 30 12 2021
medline: 13 1 2022
Statut: epublish

Résumé

The COVID-19 pandemic led to the implementation of alternative care modalities (eg, teleconsultations and task shifting) that will continue to be implemented in parallel to traditional care after the pandemic. An ideal balance between alternative and traditional care modalities is unknown. To quantify the ideal postpandemic balance between alternative and traditional care modalities among patients with chronic illness and to qualify the circumstances in which patients consider it appropriate to replace traditional care with alternative care. This survey study invited 5999 adults with chronic illness in ComPaRe, a French nationwide e-cohort of adults with chronic conditions who volunteer their time to participate in research projects, to participate in this study, which was performed from January 27 to February 23, 2021. Participants rated the ideal proportion at which they would use 3 alternative care modalities instead of the traditional care equivalent on a 0% to 100% scale (with 0% indicating using alternative care modalities for none of one's future care and 100% indicating using alternative care modalities for all of one's future care) of their overall future care: (1) teleconsultations, (2) online symptom-checkers to react to new symptoms, and (3) remote monitoring to adapt treatment outside consultations. The median ideal proportion of alternative care use was calculated. Perceived appropriate circumstances in which each alternative modality could replace traditional care were collected with open-ended questions. Analyses were performed on a weighted data set representative of patients with chronic illness in France. Of the 5999 invited individuals, 1529 (mean [SD] age, 50.3 [14.7] years; 1072 [70.1%] female) agreed to participate (participation rate, 25.5%). Participants would choose teleconsultations for 50.0% of their future consultations (IQR, 11.0%-52.0%), online symptom-checkers over contacting their physician for 22.0% of new symptoms (IQR, 2.0%-50.0%), and remote monitoring instead of consultations for 52.3% of their treatment adaptations (IQR, 25.4%-85.4%). Participants reported 67 circumstances for which replacing traditional with alternative care modalities was considered appropriate, including 31 care activities (eg, prescription renewal and addressing acute or minor complaints), 25 patient characteristics (eg, stable chronic condition and established patient-physician relationship), and 11 required characteristics of the alternative care modalities (eg, quality assurance). Results of this survey study suggest that after the pandemic, patients would choose alternative over traditional care for 22% to 52% of the time across different care needs. Participants proposed 67 criteria to guide clinicians in replacing traditional care with alternative care. These findings provide a guide for redesigning care in collaboration with patients after the pandemic.

Identifiants

pubmed: 34964850
pii: 2787586
doi: 10.1001/jamanetworkopen.2021.41233
pmc: PMC8717105
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2141233

Références

Prev Chronic Dis. 2020 Sep 17;17:E106
pubmed: 32945769
Musculoskelet Surg. 2020 Dec;104(3):227-228
pubmed: 33205378
Patient. 2008 Jul 1;1(3):211-22
pubmed: 22272927
J Clin Epidemiol. 2017 Feb;82:71-78.e2
pubmed: 27789316
Oncologist. 2021 Apr;26(4):e679-e685
pubmed: 33453121
BMJ Qual Saf. 2019 Nov;28(11):875-886
pubmed: 31015376
BMJ Qual Saf. 2021 Mar;30(3):236-239
pubmed: 32763977
Acta Diabetol. 2021 May;58(5):587-593
pubmed: 33439330
J Clin Epidemiol. 2020 Aug;124:139-148
pubmed: 32380177
BMC Med. 2014 Jul 02;12:109
pubmed: 24989988
Mayo Clin Proc. 2020 Mar;95(3):504-512
pubmed: 31619365
N Engl J Med. 2012 Jul 5;367(1):1-3
pubmed: 22716935
Lancet. 2021 Jul 3;398(10294):41-52
pubmed: 34217399
BMC Fam Pract. 2021 Jun 26;22(1):133
pubmed: 34172009
Ann Surg. 2020 Sep 1;272(3):e174-e180
pubmed: 32520742
Clin Microbiol Infect. 2021 Feb;27(2):160-162
pubmed: 33190796
BJGP Open. 2021 Jun 30;5(3):
pubmed: 33712502
J Med Internet Res. 2020 Oct 22;22(10):e20748
pubmed: 33006938
World Neurosurg. 2021 Sep;153:e308-e314
pubmed: 34224882

Auteurs

Theodora Oikonomidi (T)

Université de Paris, Centre de Recherche Epidémiologie et StatistiqueS (CRESS), Institut National de la santé et de la recherche médicale (INSERM), Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE), Paris, France.
Clinical Epidemiology Unit, Hôtel-Dieu Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Philippe Ravaud (P)

Université de Paris, Centre de Recherche Epidémiologie et StatistiqueS (CRESS), Institut National de la santé et de la recherche médicale (INSERM), Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE), Paris, France.
Clinical Epidemiology Unit, Hôtel-Dieu Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.

Diana Barger (D)

University of Bordeaux, ISPED, Inserm Bordeaux Population Health, Team EMOS, UMR 1219, Bordeaux, France.

Viet-Thi Tran (VT)

Université de Paris, Centre de Recherche Epidémiologie et StatistiqueS (CRESS), Institut National de la santé et de la recherche médicale (INSERM), Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE), Paris, France.
Clinical Epidemiology Unit, Hôtel-Dieu Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH